Back < 1 2 3 4 5 6 7 8>

GMX RESOURCES INC. Announces Launch of "At The Market" Offering of 9.25%
Series B Cumulative Preferred Stock December 14, 2010

Icagen (ICGN) Enters ATM Sales Agreement with McNicoll, Lewis & Vlak LLC December 10, 2010

Inside Wall Street: Tiny Spectrum Pharmaceuticals Is Getting Plenty of Attention December 6, 2010

AMAG Pharma: A 'Buy' Signal for Biotech's Best Value Play December 01, 2010

AMAG Pharmaceuticals "buy" November 30, 2010

McNicoll Lewis & Vlak Starts Æterna Zentaris (AEZS) at Buy; Sales Revenue and Funded Phase III Trials
Support Perifosine Development November 29, 2010

McNicoll Lewis & Vlak Upgrades AMAG Pharmaceuticals (AMAG) to Buy; Highly Encouraged November 29, 2010

UPDATE 2-AMAG Pharma iron drug does not need black box; shrs up November 29, 2010

Inhibitex Trading Higher, Following $20 Share Sale Announcement (INHX) November 24, 2010

Inhibitex Announces $20M Offering November 24, 2010

McNicoll Lewis & Vlak Upgrade Affymax, Inc. (AFFY) to Buy;
Increased Confidence for Hematide Approval in DialysisNovember 23, 2010

Aastrom Rises, Investors Start to See Tech Benefits November 9, 2010

Taseko Mines Announces "At-The-Market" Issuance Program October 19,2010

McNicoll, Lewis & Vlak Initiates Coverage on Royal Gold (RGLD) with a Buy; The Gold Sector in One StockOctober 7, 2010

McNicoll, Lewis & Vlak Downgrades AMAG Pharmaceuticals to Hold Based on new Uncertainties September 27, 2010

Analyst Comment by Christopher James at McNicoll, Lewis & Vlak LLCSeptember 24, 2010

Icagen Extends Pfizer AllianceSeptember 24, 2010

Today’s Big Losers: ARNA, NEE, BCRX, ICGNSeptember 15, 2010

McNicoll Lewis Vlak Downgrades Icagen (ICGN) to Sell; ICAA-105665 UpdateSeptember 15, 2010

Top 10 ‘Buy’-Rated Stocks Under $5September 9, 2010

Top 10 Buy-Rated Stocks Under $5 September 5, 2010

$5 Stocks That Analysts Expect to DoubleAugust 2, 2010

Reliance Industries circling Quicksilver Resources July 19, 2010

Vivus’s Rejection by Diet Pill Panel Threatens Rival CandidatesJuly 16, 2010

Vivus Shares Increase on ‘Benign’ FDA Staff Review of Diet Pill’s SafetyJuly 13, 2010

Fen-Phen Risks Won’t Color U.S. FDA Diet Pill ReviewJuly 7, 2010

McNicoll, Lewis & Vlak LCC Maintains Buy Rating on XOMA Limited (XOMA)April 14, 2010

UPDATE 2- Novavax reports positive data from flu vaccine studyMarch 24, 2010

North and South American Stock Rating Changes, New CoverageMarch 5, 2010

Back < 1 2 3 4 5 6 7 8>